Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on SUCAMPO PHARMACEUTICALS, I
03/07/18 FY 2017 Earnings Release (Projected)
05/09/18 Q1 2018 Earnings Release (Projected)
08/07/18 Interim 2018 Earnings Release (Projected)
11/08/18 Q3 2018 Earnings Release (Projected)
Past events on SUCAMPO PHARMACEUTICALS, I
12/04/17 Mizuho Americas Global Investor Conference
11/28/17 | 05:30pm Piper Jaffray Health Care Conference
11/16/17 | 03:00pm R&D Day
11/01/17 Q3 2017 Earnings Release
Upcoming sector events for SUCAMPO PHARMACEUTICALS, I
12/11/17 INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #2896
12/11/17 INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #2585
12/11/17 | 09:30pm JUNO THERAPEUTICS INC : American Society of Hematology Meeting - Abstract #742
12/11/17 | 10:30pm JUNO THERAPEUTICS INC : American Society of Hematology Meeting - Abstract #805
Past sector events for SUCAMPO PHARMACEUTICALS, I
12/10/17 | 02:15pm INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #322
12/10/17 | 04:00pm INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #381
12/10/17 | 11:15pm BLUEBIRD BIO INC : American Society of Hematology Meeting - Abstract #526
12/10/17 | 11:30pm BLUEBIRD BIO INC : American Society of Hematology Meeting - Abstract #527
Annual publications
Previous yearNext Year
Annual results2014201520162017 (e)2018 (e)
Sales
Million $
Released
Forecast
Spread
115
115
0,74%
153
141
9,0%
230
223
3,1%

253

252
Operating income (EBITDA)
Million $
Released
Forecast
Spread
33,6
38,6
-13%
56,5
56,5
-0,11%
118
115
2,7%

120

120
Operating profit (EBIT)
Million $
Released
Forecast
Spread
32,5
31,3
3,8%
55,9
51,2
9,0%
107
107
-0,38%

55,2

100
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
13,1
15,4
-15%
33,4
28,3
18%
18,5
17,7
4,7%

-153

51,7
EPS
 $
Released
Forecast
Spread
0,29
0,28
3,6%
0,73
0,61
19%
0,42
0,49
-14%

-2,13

0,81
Announcement Date03/04/201503/08/201603/08/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ1
2017
Q2
2017
Q3
2017
Q4
2017 (e)
Q1
2018 (e)
Sales
Million $
Released
Forecast
Spread
56,3
54,1
4,0%
59,9
56,4
6,2%
61,3
58,0
5,5%

75,2

58,8
Operating income (EBITDA)
Million $
Released
Forecast
Spread
28,0
30,7
-8,9%
27,4
27,1
1,2%
30,8
27,2
13%

37,1

24,5
Operating profit (EBIT)
Million $
Released
Forecast
Spread
25,5
27,3
-6,6%
20,9
23,5
-11%
29,3
21,1
39%

34,9


Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
4,62
13,1
-65%
-181
7,95
-2 380%
10,4
4,10
153%

7,44

6,29
EPS
 $
Released
Forecast
Spread
0,10
0,16
-36%
-3,92
0,17
-2 362%
0,19
0,10
84%

0,12

0,10
Announcement Date05/03/201708/02/201711/01/2017

© 2017 Thomson Reuters
© 2017 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise